Lisa Kerber outlines how the pharma industry can take advantage of combining new clinical data sources such as diagnostics, or lab data, with AI to deliver on the promise of improving outcomes.
Lisa Kerber
Advertisement
Lisa Kerber, Chief Operating Officer at PrognosKerber has more than two decades of experience supporting the Life Sciences industry and specializes in healthcare informatics. Before joining Prognos, Kerber served in various roles at QuintilesIMS (formerly IMS Health) for more than 20 years.
Articles by Lisa Kerber
Advertisement
Latest Updated Articles
AI & Lab Data: Enabling Decision-Making in Real TimePublished: September 4th 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
4
Alkermes Reveals CEO Succession Plan Following Richard Pops’ Retirement Announcement
5